Case number 1:23-cv-00229
Catalyst Pharmaceuticals, Inc. et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 5, 2023 | 8 | NOTICE of Voluntary Dismissal by Catalyst Pharmaceuticals, Inc., SERB SA as to all Defendants (Viceconte, Christopher) (Entered: 05/05/2023) (1) |
| May 5, 2023 | N/A | CASE CLOSED (dlw) (Entered: 05/05/2023) (0) |
| May 5, 2023 | 9 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Notice of Voluntary Dismissal)(mdb) (Entered: 05/05/2023) (Main Document) (1) |
| May 5, 2023 | 9 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Notice of Voluntary Dismissal)(mdb) (Entered: 05/05/2023) (Notice of Voluntary Dismissal) (1) |
| Mar 9, 2023 | N/A | CORRECTING ENTRY: D.I. 7 has been deleted from the docket and re-filed using the proper event code: ANDA Form found under civil, other documents. (dlw) (Entered: 03/09/2023) (0) |
| Mar 8, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 03/08/2023) (0) |
| Mar 7, 2023 | 7 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Catalyst - 1/27/2023; SERB - 1/30/2023. Date of Expiration of Patents: Various. Thirty Month Stay Deadline: 7/30/2025. (dlw) (Entered: 03/09/2023) (1) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Main Document) (24) |
| Mar 2, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 03/02/2023) (3) |
| Mar 2, 2023 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,626,088; US 10,793,893; US 11,060,128; US 11,268,128; US 11,274,331; US 11,274,332. (jfm) (Entered: 03/02/2023) (1) |
| Mar 2, 2023 | 4 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Catalyst Pharmaceuticals, Inc. (jfm) (Entered: 03/02/2023) (1) |
| Mar 2, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by SERB SA. (jfm) (Entered: 03/02/2023) (1) |
| Mar 2, 2023 | 6 | Summons Issued as to Lupin Inc., Lupin Ltd., and Lupin Pharmaceuticals, Inc. on 3/2/2023. (Attachments: # 1 Summons Issued Lupin Ldt., # 2 Summons Issued Lupin Pharmaceuticals, Inc.)(jfm) (Entered: 03/02/2023) (Main Document) (2) |
| Mar 2, 2023 | 6 | Summons Issued as to Lupin Inc., Lupin Ltd., and Lupin Pharmaceuticals, Inc. on 3/2/2023. (Attachments: # 1 Summons Issued Lupin Ldt., # 2 Summons Issued Lupin Pharmaceuticals, Inc.)(jfm) (Entered: 03/02/2023) (Summons Issued Lupin Ldt.) (2) |
| Mar 2, 2023 | 6 | Summons Issued as to Lupin Inc., Lupin Ltd., and Lupin Pharmaceuticals, Inc. on 3/2/2023. (Attachments: # 1 Summons Issued Lupin Ldt., # 2 Summons Issued Lupin Pharmaceuticals, Inc.)(jfm) (Entered: 03/02/2023) (Summons Issued Lupin Pharmaceuticals, Inc.) (2) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Exhibit 1) (23) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Exhibit 2) (30) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Exhibit 3) (30) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Exhibit 4) (30) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Exhibit 5) (30) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Exhibit 6) (30) |
| Mar 2, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023) (Civil Cover Sheet) (2) |
